Cardiff Oncology Inc (CRDF) — Working Capital to Net Assets Ratio
Cardiff Oncology Inc (CRDF) has a Working Capital to Net Assets ratio of 96.4% as of December 2025. Working capital of $43.73 Million (current assets of $60.13 Million minus current liabilities of $16.39 Million) is measured against net assets of $45.39 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how leveraged is Cardiff Oncology Inc's balance sheet to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Cardiff Oncology Inc Working Capital to Net Assets (2009–2025)
This chart shows how Cardiff Oncology Inc's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2009 to 2025. As of December 2025, the ratio stands at 96.4%, reflecting working capital of $43.73 Million against net assets of $45.39 Million USD. Check CRDF goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Cardiff Oncology Inc (2009–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Cardiff Oncology Inc from 2009 to 2025, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see CRDF stock market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 96.4% | $43.73 Million | $45.39 Million | $60.13 Million | $16.39 Million | ▼ -2.0 pp |
| 2024 | 98.4% | $81.63 Million | $82.95 Million | $95.05 Million | $13.43 Million | ▲ +2.4 pp |
| 2023 | 96.0% | $66.97 Million | $69.74 Million | $77.41 Million | $10.44 Million | ▼ -1.3 pp |
| 2022 | 97.3% | $103.48 Million | $106.34 Million | $111.28 Million | $7.81 Million | ▼ -2.1 pp |
| 2021 | 99.4% | $139.57 Million | $140.42 Million | $146.13 Million | $6.56 Million | ▲ +0.1 pp |
| 2020 | 99.3% | $127.24 Million | $128.16 Million | $133.36 Million | $6.12 Million | ▲ +9.4 pp |
| 2019 | 89.9% | $6.57 Million | $7.31 Million | $11.35 Million | $4.78 Million | ▼ -7.3 pp |
| 2018 | 97.2% | $9.80 Million | $10.08 Million | $12.77 Million | $2.96 Million | ▲ +12.3 pp |
| 2017 | 84.9% | $5.52 Million | $6.51 Million | $9.47 Million | $3.95 Million | ▼ -72.7 pp |
| 2016 | 157.6% | $31.15 Million | $19.77 Million | $38.95 Million | $7.80 Million | ▲ +34.0 pp |
| 2015 | 123.6% | $60.18 Million | $48.70 Million | $68.38 Million | $8.20 Million | ▼ -149.6 pp |
| 2014 | 273.1% | $22.80 Million | $8.35 Million | $27.29 Million | $4.49 Million | ▲ +155.2 pp |
| 2013 | 118.0% | $24.06 Million | $20.39 Million | $26.07 Million | $2.01 Million | ▼ -347.2 pp |
| 2012 | 465.2% | $10.09 Million | $2.17 Million | $10.82 Million | $730.00K | ▲ +451.3 pp |
| 2011 | 13.9% | $-587.71K | $-4.23 Million | $842.17K | $1.43 Million | ▼ -48.9 pp |
| 2010 | 62.8% | $-3.14 Million | $-5.00 Million | $284.74K | $3.42 Million | ▼ -4.7 pp |
| 2009 | 67.5% | $-2.56 Million | $-3.79 Million | $650.00K | $3.21 Million | — |